Celgene Corporation (OQ:CELG)

Business Focus: Bio Therapeutic Drugs

Recent Price for CELG
USD 143.890 +0.110 (+0.077%)
NSQ Delayed 15 minutes
Sep 22 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
144.190 144.590 44.75 3,549,466 112,572.44
1-Day Low 52-Week Low Yield Avg. Volume  
141.750 96.930 0.0% 3,405,522  

Latest 10 SEC filings (by transaction date) for CELG within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -9,250  
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Common Stock S - Open market or private sale -9,250 $141.56
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 9,250 $33.88
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -9,250  
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Common Stock S - Open market or private sale -9,250 $139.03
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 9,250 $24.97
Aug 14/17 Aug 10/17 Mario Ernest Direct Ownership Common Stock S - Open market or private sale -18,506 $130.52
Aug 3/17 Aug 2/17 Kaplan Gilla Direct Ownership Common Stock S - Open market or private sale -7,500 $134.52
Aug 2/17 Aug 1/17 Curran Terrie Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -1,500  
Aug 2/17 Aug 1/17 Curran Terrie Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -558 $135.18
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for CELG within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -9,250  
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Common Stock S - Open market or private sale -9,250 $141.56
Sep 14/17 Sep 12/17 Kaplan Gilla Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 9,250 $33.88
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -9,250  
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Common Stock S - Open market or private sale -9,250 $139.03
Sep 6/17 Sep 5/17 Casey Michael D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 9,250 $24.97
Aug 31/17 Feb 27/17 Mario Ernest Direct Ownership Common Stock S - Open market or private sale -12,000 $121.24
Aug 14/17 Aug 10/17 Mario Ernest Direct Ownership Common Stock S - Open market or private sale -18,506 $130.52
Aug 3/17 Aug 2/17 Kaplan Gilla Direct Ownership Common Stock S - Open market or private sale -7,500 $134.52
Aug 2/17 Aug 1/17 Curran Terrie Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -1,500  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $CELG

StockTwits